About Daniel Becker
Daniel Becker is a Matchpoint Therapeutics director. The company develops drugs for immune diseases. He is also managing director at Access Biotechnology.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Becker in the role, so the role may have started earlier or lasted longer.
Matchpoint Therapeutics Inc. Current
Director; Managing Director, Access Biotechnology
2022 – Present · Watertown, MA
Matchpoint develops oral drugs that bind hard-to-treat protein targets in immune diseases.
AB
Access Biotechnology Current
Managing Director
Key Colleagues at Startups
The people Daniel Becker works with at each company, as listed on that company's latest Form D.
Matchpoint Therapeutics Inc. · Form D, Nov 20, 2026

Andre Turenne
Director; President & Chief Executive Officer
BM
Brian Matesic
Director; Principal, Norwest
KP
Kanishka Pothula
Director; Managing Partner, Nextech
JH
Jason Hafler
Director; Managing Director, Sanofi Ventures
BB
Bruce Booth
Chairman; Partner, Atlas Venture
DN
Donald Nicolson
Director

Jared Cumming
Chief Scientific Officer

John O'Malley
Chief Medical Officer